Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Bio-Technology General receives added patent protection for novel anticoagulant

March 8, 1999

Pharmacia & Upjohn and Centocor to copromote Fragmin in unstable angina

March 8, 1999

Antithrombotic P2T antagonists in development at Astra

March 8, 1999

Randomized comparison of aspirin, aspirin + warfarin and aspirin + ticlopidine following stenting

March 5, 1999

Platelet aggregation inhibitors in development at SmithKline Beecham

March 4, 1999

FDA grants priority review to Boehringer Ingelheim's new stroke therapy

March 4, 1999

Vasoflux is superior to other anticoagulants due to its unique mechanism of action

March 3, 1999

Corvas reacquires rights to injectable anticoagulant from Schering-Plough

March 2, 1999

Emisphere Technologies updates oral heparin development program

March 2, 1999

European CPMP recommends approval of Integrilin for acute coronary syndrome

March 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...